Targeting CD38 in Subclinical Antibody-mediated Rejection in HLA-incompatible Kidney Transplantation: A Case Report
Transplant Direct
.
2024 Jul 18;10(8):e1685.
doi: 10.1097/TXD.0000000000001685.
eCollection 2024 Aug.
Authors
Ondrej Viklicky
1
2
,
Petra Hruba
2
,
Marek Novotny
1
,
Martin Kment
3
,
Matej Roder
4
,
Philip F Halloran
5
,
Georg A Böhmig
6
Affiliations
1
Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
2
Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
3
Department of Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
4
Department of Immunogenetics, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
5
Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada.
6
Division of Nephrology and Dialysis, Department of Medicine III, Medical University Vienna, Vienna, Austria.
PMID:
39035116
PMCID:
PMC11259386
DOI:
10.1097/TXD.0000000000001685
No abstract available